Date:11/5/2007

s product offerings through internal development or acquisition and to integrate acquired products into its business; the Company's ability to realize the anticipated benefits of its acquisition of Vascular Architects and other acquisitions; disruption at the Company's single manufacturing facility; the general uncertainty related to seeking regulatory approvals for the Company's products, particularly in the United States; potential claims of third parties that the Company's products infringe their intellectual property rights; and the risks and uncertainties described in the Company's Annual Report on Form 10-K for the year ended December 31, 2006, under the heading "Risk Factors," which has been filed with the SEC and is available on the Company's investor relations website at http://www.lemaitre.com and on the SEC's website at http://www.sec.gov, and in subsequent SEC filings. Undue reliance should not be placed on forward-looking statements, which speak only as of the date they are made. The Company undertakes no obligation to update publicly any forward-looking statements to reflect new information, events, or circumstances after the date they were made, or to reflect the occurrence of unanticipated events.

Financial Statements

LEMAITRE VASCULAR, INC (NASDAQ: LMAT)

CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS

(amounts in thousands, except share data)

(unaudited)

For the three months For the nine months

ended: ended:

September 30 September 30'/>"/>

SOURCE LeMaitre Vascular, Inc. Copyright©2007 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9
Related medicine news :

1. LeMaitre Vascular to Start Italian Sales Force
2. LeMaitre Vascular to Participate at CIBC 18th Annual Healthcare Conference
3. Antioxidants show no clear benefit against cardiovascular events, death in high-risk women
4. Waist-to-hip ratio may better predict cardiovascular risk than body mass index
5. Pot bellies linked to early signs of cardiovascular disease
6. Air pollution linked to cardiovascular risk indices in healthy young adults
7. Environmental stress probed in cardiovascular disease, diabetes
8. Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3
9. American Heart Association Enhances eLearning for Emergency Cardiovascular Care (ECC)
10. Researchers provide genetic associations from a genome-wide scan for cardiovascular disease traits
11. GrantAdler Shipping Novel Implantable Vascular Access Port